Wikidata entity: Q422970
C₁₇H₂₀N₂S (P274)
Quantities
| P4250 | defined daily dose | 25 |
| P2067 | mass | 284.13472 |
| P3780 | active ingredient in | ... | Q47521986 (Phenergan) | Phenergan |
| P3780 | active ingredient in | ... | Q48828198 (Phenadoz) | Phenadoz |
| P3780 | active ingredient in | ... | Q48829178 (Promethegan) | Promethegan |
| P233 | canonical SMILES | String | CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C | ??? |
| P373 | Commons category | String | Promethazine | ??? |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q682 (sulfur) | sulfur |
| P31 | instance of | ... | Q59199015 (group of stereoisomers) | group of stereoisomers |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P8026 | LiverTox likelihood score | ... | Q83284667 (LiverTox toxicity likelihood category E) | LiverTox toxicity likelihood category E |
| P1987 | MCN code | String | 2934.30.30 | ??? |
| P2175 | medical condition treated | ... | Q127076 (vomiting) | vomiting |
| P2175 | medical condition treated | ... | Q81938 (pain) | pain |
| P2175 | medical condition treated | ... | Q309067 (motion sickness) | motion sickness |
| P2175 | medical condition treated | ... | Q18478450 (postoperative complications) | postoperative complications |
| P1705 | native label | Monolingualtext | Promethazine | ??? |
| P129 | physically interacts with | ... | Q309513 (Histamine receptor H1) | Histamine receptor H1 |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q55434 (pethidine) | pethidine |
| P769 | significant drug interaction | ... | Q58396 (imipramine) | imipramine |
| P769 | significant drug interaction | ... | Q58397 (amitriptyline) | amitriptyline |
| P769 | significant drug interaction | ... | Q58614 (loxapine) | loxapine |
| P769 | significant drug interaction | ... | Q58713 (clomipramine) | clomipramine |
| P769 | significant drug interaction | ... | Q81225 (morphine) | morphine |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q174723 (codeine) | codeine |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q377270 (dihydrocodeine) | dihydrocodeine |
| P769 | significant drug interaction | ... | Q303646 (hydromorphone) | hydromorphone |
| P769 | significant drug interaction | ... | Q221361 (clozapine) | clozapine |
| P769 | significant drug interaction | ... | Q228143 (zuclopenthixol) | zuclopenthixol |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q407535 (oxycodone) | oxycodone |
| P769 | significant drug interaction | ... | Q407541 (fentanyl) | fentanyl |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q408535 (quetiapine) | quetiapine |
| P769 | significant drug interaction | ... | Q407592 (tramadol) | tramadol |
| P769 | significant drug interaction | ... | Q407721 (buprenorphine) | buprenorphine |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q423292 (paliperidone) | paliperidone |
| P769 | significant drug interaction | ... | Q423498 (trimipramine) | trimipramine |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q411188 (aripiprazole) | aripiprazole |
| P769 | significant drug interaction | ... | Q414463 (tapentadol) | tapentadol |
| P769 | significant drug interaction | ... | Q2622907 (periciazine) | periciazine |
| P769 | significant drug interaction | ... | Q2991856 (trihexyphenidyl) | trihexyphenidyl |
| P769 | significant drug interaction | ... | Q7553347 (sodium oxybate) | sodium oxybate |
| P279 | subclass of | ... | Q12140 (medication) | medication |
| P279 | subclass of | ... | Q16023748 (phenothiazine) | phenothiazine |
| P2868 | subject has role | ... | Q1328275 (H1 antagonist) | H1 antagonist |
| P2868 | subject has role | ... | Q2853347 (antipruritic) | antipruritic |
| P2868 | subject has role | ... | Q3271533 (dopamine antagonist) | dopamine antagonist |
| P2868 | subject has role | ... | Q50430264 (anti-allergic agents) | anti-allergic agents |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | promethazine | ??? |
Why not click here or view trends?
log id: 74689